CH

CHEIL BIO CO., LTD.

Develops and manufactures veterinary medicines and functional feed additives.

052670 | KO

Overview

Corporate Details

ISIN(s):
KR7052670007
LEI:
Country:
South Korea
Address:
경기 안산시 목내동 456-2, 안산시

Description

CHEIL BIO CO., LTD. is a company that develops, manufactures, and markets a wide range of advanced veterinary products. The company focuses on improving the health and productivity of livestock through solutions based on extensive research and biotechnology. Its core offerings include animal medicines, such as antibiotics and antimicrobials, and functional feed additives. These products cater to a diverse market, including the swine, poultry, cattle, and aquaculture sectors, as well as companion animals. The company leverages its dedicated research and development capabilities to create high-quality, market-competitive products and aims to achieve global technological competitiveness in the animal health industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-09 00:00
기타시장안내 (상장폐지결정 효력정지 가처분신청 기각 및 상장폐지 절차 관련 안내)
Korean DOC 6.5 KB
2025-09-15 00:00
[기재정정]액면주식ㆍ무액면주식전환결정
Korean HTML 16.9 KB
2025-09-15 00:00
[기재정정]주요사항보고서(감자결정)
Korean HTML 31.6 KB
2025-09-10 00:00
주요사항보고서(소송등의제기)
Korean HTML 5.7 KB
2025-08-26 00:00
주권매매거래정지기간변경 (주식의 병합, 분할 등 전자등록 변경, 말소)
Korean HTML 4.9 KB
2025-08-26 00:00
횡령ㆍ배임혐의진행사항
Korean HTML 8.4 KB
2025-08-14 00:00
[기재정정]사업보고서 (2024.12)
Korean HTML 1.0 MB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 780.5 KB
2025-08-14 00:00
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean HTML 14.1 KB
2025-08-01 00:00
임시주주총회결과
Korean HTML 14.4 KB
2025-08-01 00:00
[기재정정]액면주식ㆍ무액면주식전환결정
Korean HTML 15.4 KB
2025-08-01 00:00
[기재정정]주요사항보고서(감자결정)
Korean HTML 35.6 KB
2025-07-21 00:00
횡령ㆍ배임혐의진행사항
Korean HTML 6.9 KB
2025-07-18 00:00
[기재정정]주주총회소집결의 (임시주주총회)
Korean HTML 9.6 KB
2025-07-18 00:00
액면주식ㆍ무액면주식전환결정
Korean HTML 10.6 KB

Automate Your Workflow. Get a real-time feed of all CHEIL BIO CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHEIL BIO CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHEIL BIO CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.